Citadel Advisors’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6759 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6740 |
|
|
2024
Q4 | – | Sell |
-275,951
| Closed | -$1.01M | – | 6614 |
|
|
2024
Q3 | $1.01M | Buy |
+275,951
| New | +$1.01M | ﹤0.01% | 3102 |
|
|
2024
Q2 | – | Sell |
-4,109
| Closed | -$17.5K | – | 6641 |
|
|
2024
Q1 | $17.5K | Sell |
4,109
-102,726
| -96% | -$438K | ﹤0.01% | 5576 |
|
|
2023
Q4 | $192K | Buy |
+106,835
| New | +$192K | ﹤0.01% | 4626 |
|
|
2023
Q2 | – | Sell |
-27,129
| Closed | -$109K | – | 6349 |
|
|
2023
Q1 | $109K | Sell |
27,129
-1,535,669
| -98% | -$6.16M | ﹤0.01% | 4881 |
|
|
2022
Q4 | $2.09M | Buy |
1,562,798
+32,013
| +2% | +$42.9K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $3.02M | Buy |
1,530,785
+9,849
| +0.6% | +$19.4K | ﹤0.01% | 2346 |
|
|
2022
Q2 | $3.62M | Sell |
1,520,936
-1,562
| -0.1% | -$3.72K | ﹤0.01% | 2184 |
|
|
2022
Q1 | $6.06M | Buy |
1,522,498
+881
| +0.1% | +$3.51K | ﹤0.01% | 1894 |
|
|
2021
Q4 | $16.5M | Buy |
+1,521,617
| New | +$16.5M | ﹤0.01% | 1060 |
|